Redox, the company driving interoperability in healthcare, has announced a partnership with Spire Health, the leading digital healthcare company for respiratory remote patient monitoring (RPM). Together, Spire Health and Redox will integrate RPM data into health system electronic medical records (EMRs) to improve both billing and clinical effectiveness. As a result, providers can now visualize Spire patient data directly in their EMR allowing respiratory RPM to function as a seamless extension of their organization.

According to the American Lung Association (ALA), there are more than 24 million American adults living with chronic obstructive pulmonary disease (COPD) and other health issues related to respiratory function. There is no treatment for COPD, and this progressive disease can result in frequent hospital admissions due to common aggravations. Spire Health’s platform offers providers a way to see early changes in patient condition so they can proactively intervene to prevent hospitalization.

“As Spire continues to expand our customer base and patient numbers across the US, the invaluable data our sensors capture is increasingly driving decision making in pulmonary practices,” said Phil Golz, VP of Commercial, Spire Health. “It is important that this rich clinical data is easily accessible to healthcare providers so that they can better understand their patients’ health and make timely decisions to improve outcomes. Partnering with Redox means that we can make Spire data available to almost every pulmonary physician through the patient’s chart, which is a huge step forward and a milestone in our company history.”

“Since respiratory illness has come to the forefront over the past couple years, it’s become more of an imperative that patients have access to the best solutions for managed respiratory care,” explains Redox Director of Product Brandon Gardner. “Spire Health and Redox streamline the flow of key clinical, financial, and administrative information between patients, technology, and providers. This integration ensures that pulmonologists can offer RPM without adding any extra burden or time to their busy staff.”

If you are ever involved in a car accident, it is important to remember to avoid making any serious mistakes. These mistakes could potentially lead to further injuries or even criminal charges. In this article, you will learn about some of the most common and serious mistakes that people make following a car accident.

Delaying Medical Care

Accidents happen all over the state of Georgia, and as soon as you’ve been in a crash, you have to get your injuries treated to make sure everything’s okay, and so that the doctors can see the full-scale damage to your body. According to the advice from this Atlanta based car accident lawyer, documenting your fresh injuries as soon as possible is key to getting the full value of your claim. This means you’re having a win-win situation if you go to the hospital right away.

Make sure to never delay going to the hospital after a car accident. Many people make the mistake of thinking that they don’t have any serious injuries, and as a result, they delay going to the hospital. This is often a costly mistake, as many injuries sustained in car accidents do not show symptoms until later on. By delaying medical care, you could end up making your injuries worse and increasing the amount of time it takes for you to recover.

Car accident injuries can often have long-lasting effects, so visiting the hospital right after is your best call. Otherwise, you’re at the risk of having permanent consequences.

Throwing Away The Medical Bills

There are tons of hospital bills and other medical bills that will come after a car accident. It is important to keep every single one of these bills. Some people make the mistake of throwing them away thinking that their insurance will cover it all. Insurance does not always cover everything and you might need those bills to show what treatments were received.

The medical bills you will get during your visits to the hospital are the following:

• Your ambulance ride
• Any x-rays or scans performed
• Your emergency room visit
• Your inpatient stay
• Your outpatient visits
• Rehabilitation and physical therapy bills
• Prescription medications
• Over the counter medications related to your accident

Throwing away the medical bills is a serious mistake to avoid when involved in a car accident. You should also make a copy of the invoices and keep them in a safe place. If you have any questions about your insurance coverage, contact your insurance company. They will be able to help you understand what is covered and what is not. Having all of these bills can also help if you need to go to court because of the accident.

Not Cooperating

You need to notify the authorities if you are in a car accident, even if it seems minor. Many people make the mistake of not cooperating with the police and end up getting into more trouble. You may think that notifying the authorities will only make the situation worse, but this is not always true. If you do not cooperate, you could be charged with a crime or ticketed for violating traffic laws. It is best to let the professionals handle the situation and cooperate with their requests. Remember, your safety and well-being are a top priority.

Be truthful and honest with the police. If you are not sure about something, ask for clarification. Do not try to guess or lie about what happened. Lying to the police can lead to more problems and could even land you in jail. The truth will come out eventually, so it is best, to tell the truth from the beginning.

Follow the instructions of the police officer. If you are asked to remain at the scene, do not leave until instructed to do so by the officer. If you are asked to go to a particular location for questioning, go there as quickly as possible. Do not get into an argument with the officer or refuse their requests. Remember, they are just doing their job and trying to keep everyone safe.

Not Getting The Official Report

If this goes to court, you’ll need a copy of the accident report. You’re not going to be able to get very far without it. Make sure you get a copy of the official report as soon as possible after the accident.

This is definitely one of the most serious mistakes that you can make when involved in a car accident. If you don’t have an official report, it’s going to be very difficult to prove what happened during the accident and who was at fault. This could end up costing you a lot of time and money in court if it goes to trial. Make sure you get a copy of the official report as soon as possible after the accident so that you have all the information you need to protect yourself and your case.​

Ignoring The Scene Of The Accident

You have to document the scene of the accident if you want to have a chance of winning in court. If you leave the scene, you’re compromising your case and could wind up with a lesser settlement or no settlement at all.

Take pictures of the damage to both cars, as well as any injuries that resulted from the accident. Get witness contact information, and write down everything you can remember about what happened. The more evidence you have, the better your chances are of getting compensated for your losses.

Doing Everything On Your Own

Never dive into these things without a legal advisor as they’re your best chance to get compensated for the damages you deserve. You may think you’re doing everything right, but without the insight of a professional, you could be making some serious mistakes.

When it comes to car accidents, there are plenty of things that can go wrong if you’re not careful. Here are three big ones to avoid like trying to handle negotiations with the insurance company on your own or signing any documents without reading them carefully first. Many people also agree to a settlement before you know all the facts about their case.

A lawyer will know how much you can get out of your situation and how to properly file a case. Trying to go it alone can lead to frustration and a lot less money in your pocket.

Being in a car accident is a dangerous and scary thing and delaying medical care is a huge mistake, along with throwing away medical bills. You have to cooperate with authorities, as well as be truthful in court, and always get a copy of the police report. Never ignore the scene of the accident since it can very much help your case, and make sure that you hire a lawyer who will guide you through the process. This will get you compensated in no time!

The head of the NHS revealed today that a breakthrough targeted medication treating lung cancer would be made accessible to anybody who qualifies, owing to a new drug deal. Sotorasib is a drug that targets a genetic abnormality known as the “death star” by doctors and scientists. It has been shown in clinical studies to stop lung cancer from spreading for seven months. Because of an early access arrangement with the manufacturer, NHS patients in England were the first in Europe to receive the medicine in September last year.

Approximately 100 people have already benefited from the procedure.The NHS chief executive, Amanda Pritchard, announced the new contract, saying it would assist even more patients, including 600 people qualifying for the “cutting edge” treatment each year. The lethal ‘death star’ mutant of the KRAS gene, so named for its spherical form and impenetrable nature, affects about one out of every eight lung cancer patients.

This new medicine has been in development for more than 40 years, and it is the latest deal the NHS has made as part of its promise to make more cutting-edge treatments available. The medicine, which may be given at home to enhance the user experience for patients, might also be a game-changer in the management of some of the world’s worst malignancies, such as pancreatic and colorectal tumours.

It’s also intended to provide a longer and better life than traditional chemotherapy, with fewer side effects and a higher quality of life for patients. It is an excellent news for thousands of patients and families because they will now be able to obtain this first-of-its-kind treatment thanks to another arrangement secured by the NHS, says Amanda Pritchard, NHS chief executive. From life-changing pharmaceuticals for cystic fibrosis to breakthrough cures for sickle cell disease, this is the latest in a line of deals they have reached to provide patients with the most cutting-edge cures at a reasonable cost for taxpayers. She adds that the NHS is committed to safeguarding many lives from cancer through early identification and treatment, and cancer has been emphasised throughout the outbreak, so anyone with symptoms or concerns should come forward and get examined as soon as possible.

It’s extremely interesting to see this ground-breaking medication coming into use after 40 years of study on this crucial goal, to directly help patients with lung cancer who carry this specific mutation, says Peter Johnson, NHS clinical director for cancer. As per him, the NHS is devoted to helping more lives from cancer through better diagnosis and treatment, with molecular testing with its genomics programme becoming extremely relevant for choosing the best treatment options, and this deal will make this drug readily available for patients who need it the most.

As part of the national war against cancer, they are dedicated to accelerating detection times and delivering innovative treatments, says Sajid Javid, Health and Social Care Secretary. This includes ground-breaking medicines like Sotorasib, which is the culmination of decades of research and is backed by the Cancer Drugs Fund, and will allow scores of more lung cancer patients in England to receive the care they require.

This historic agreement will go on to strengthen the NHS and assist them in making the UK’s cancer care system the finest in Europe. The NHS struck a deal, and the medicine will now be available under the Cancer Drugs Fund (CDF). This ground-breaking medication inhibits cell proliferation and cancer progression by attaching to the KRAS G12C mutation and leaving it inactive.Patients can take Sotorasib as a tablet at home, making it easier than ever to get the help they need and eliminating the necessity of inpatient hospital visits.

Lung cancer is the third most common cancer in the UK, with around 50,000 individuals diagnosed each year. This medication will primarily be used as a second-line treatment for patients with severe lung cancer and those who have had their illness progress following chemotherapy. Following a confidential deal with manufacturer Amgen that allowed the drug to enter the CDF, the NHS is now able to fast-track Sotorasib to its patients on a budget-neutral basis. Around 1,200 eligible patients are likely to benefit from therapy in the next two years.

The agreement lets patients get the new medicine while more information about its clinical and economic benefits is gathered. This will help the National Institute of Health and Clinical Excellence (NICE) decide if it should be used on a regular basis in the NHS.Over 75,000 patients have benefited from speedier accessibility to over 90 different cancer treatments thanks to the CDF in just over five years. Building on the CDF’s success, the NHS will establish a new Novel Medicines Fund later this year, which will assist faster access to non-cancer treatments and offer a total of £680 million in ringfenced healthcare spending for innovative medicines, alongside the CDF. The Innovative Medicines Fund consultation ended in February, with 96 percent of respondents supporting the new fund’s goals.

Sotorasib provides a new therapy option for eligible patients whose lung cancer is found to contain the KRAS G12C mutation, states Executive Medical Director at Amgen UK and Ireland, Dr. Tony Patrikios. Well over half of NSCLC patients had advanced or metastatic disease just at time of diagnosis, and the prognosis remained dismal across the UK. Amgen is happy with its partnership with NHS England as well as NICE to ensure that people with NSCLC who could benefit from Sotorasib can get treatment as soon as possible.

This is the latest in a series of commercial agreements reached by the NHS in the last year, securing innovative treatments for patients with a variety of conditions, including an at-home treatment for spinal muscular atrophy, a life-saving gene therapy for metachromatic leukodystrophy, and groundbreaking care for thousands of children with peanut allergies, as well as better access to the “miracle” triple therapy for cystic fibrosis.

As per a scientific brief released by the World Health Organization (WHO), the global prevalence of anxiety and sadness soared by a staggering 25% during the first year of the pandemic. The brief also discusses who has been most affected by the outbreak and outlines the impact of the virus on the provision of mental health treatments, as well as how this has changed over time.

Although 90 percent of countries surveyed previously incorporated mental health and psychosocial assistance into their COVID-19 response plans, significant gaps and concerns remain.What is known about COVID-19’s impact on global mental health is merely the tip of the iceberg, says WHO Director-General Dr Tedros Adhanom Ghebreyesus. Further, he says that this should serve as a wake-up call to all nations to give more attention to psychological health and do a greater job of raising the mental health of their communities.

Multiple sources of stress

One key reason for the surge is the tremendous stress brought on by the pandemic’s social isolation. Constraints on people’s ability to work, look for support from loved ones, and participate in their communities were all linked to this. Isolation, dread of infection, pain and death for oneself or loved ones, sadness following bereavement, and financial problems have all been identified as factors that contribute to anxiety and depression. Exhaustion has been identified as a primary factor in suicide ideation among healthcare professionals.

Young people and women are the hardest hit

The brief, which is based on a thorough evaluation of previous evidence about COVID-19’s impact on mental health and its services and includes estimates from the most recent Global Burden of Disease study, demonstrates that the pandemic has harmed young people’s mental health and that they are potentially at risk of suicidal and self-harming behaviour. It also suggests that women have been hit harder than males, and that people who have pre-existing physical health illnesses like asthma, cancer, or heart disease are more likely to experience mental health symptoms.

People with pre-existing mental disorders don’t really appear to be particularly sensitive to COVID-19 infection, according to the data . When such people do become contaminated, they are much more likely to be hospitalised, suffer from severe illness, and die than people who do not have mental illnesses. People with serious mental illnesses, like psychoses, and young people with mental illnesses are especially vulnerable.

Care inconsistencies

This rise in mental health issues has corresponded with substantial interruptions in mental health services, creating large gaps in care for people who need it the most. Mental, neurological, and drug use disorder services were the most disturbed across all critical health care services recorded by WHO Member States during much of the pandemic. Several nations also reported significant disruptions in life-saving mental health services, particularly suicide prevention.

Although the situation had improved by the end of 2021, far too many people were still unable to receive the care and assistance they needed for both pre-existing and newly developed mental health issues. Due to a lack of access to face-to-face healthcare, many people have turned to the internet for help, highlighting the critical need for dependable and effective digital solutions to be widely accessible. However, in resource-constrained countries and situations, designing and delivering digital solutions remains a major issue.

Action by WHO and countries

Since the beginning of the epidemic, WHO and allies have worked to produce and disseminate materials in a variety of dialects and forms to assist various populations in coping with and responding to COVID-19’s mental health effects. WHO, for example, published “My Hero is You,” a tale book for children aged 6 to 11, which is now accessible in 142 dialects and 61 multimedia versions, as well as a toolkit for assisting older individuals in 16 languages.

At the same time, the organisation has led an interagency mental health and psychosocial response to the pandemic in collaboration with partners such as other United Nations agencies, international non-governmental groups, and the Red Cross and Red Crescent Societies. WHO has sought to encourage the inclusion of mental health and psychosocial assistance across and within all parts of the global response during the pandemic.

The effect of COVID-19 on mental health has been acknowledged by WHO Member States, and they are taking action. According to the World Health Organization’s most recent pulse study on the continuity of essential health services, 90% of countries are trying to continue providing mental health and psychosocial assistance to COVID-19 patients and responders. Furthermore, governments stressed the importance of developing and enhancing mental health and psychosocial support services as part of increasing preparedness, response, and resistance to COVID-19 and future public health emergencies during last year’s World Health Assembly. They approved the amended Integrated Mental Health Action Plan 2013–2030 that contains a psychological health and individual counselling indicator in the event of a public health emergency.

Increase your investment

This dedication to mental health, however, must be backed by an increase in global funding. Regrettably, the situation highlights a long-standing global dearth of mental health support that persists today. According to the World Health Organization’s latest Mental Health Atlas, governments worldwide invested little over 2% of their health spending on mental health in 2020, and several low-income nations reported having fewer than one mental health worker for every 100,000 people.

While the epidemic has created attention and worry for mental health, it has also exposed historic under-investment in mental health care, says Dévora Kestel, Director of WHO’s Department of Mental Health and Substance Use. He further says that countries must move quickly to ensure that everyone has access to mental health care.